A. Kretowski et al., Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity?, IMMUNOLOGY, 99(2), 2000, pp. 320-325
L-selectin (CD62L) is a cell adhesion molecule which plays a key role in th
e initiation of leucocyte migration from blood vessels to sites of local in
flammation. The aim of this study was to investigate T-lymphocyte expressio
n of CD62L antigen and serum levels of soluble L-selectin (sL-selectin) in
subjects with clinical and preclinical type I diabetes to determine whether
they could provide surrogate markers for disease activity. CD62L selectin
expression on memory T lymphocytes was studied by cytometric analysis in 22
patients with newly diagnosed type I diabetes, 20 first-degree relatives o
f patients with type I diabetes, 14 patients with Graves' disease, and 22 h
ealthy controls. sL-selectin levels were measured by enzyme-linked immunoso
rbent assay (ELISA) in enlarged groups of subjects in these categories, as
well as in patients with long-standing type I diabetes, treated Graves' dis
ease and type II (non-insulin dependent) diabetes. L-selectin levels were a
lso related to islet autoantibodies, human leucocyte antigen (HLA) genotype
and L-selectin T668C gene polymorphisms. L-selectin expression on memory T
lymphocytes was reduced in newly diagnosed diabetes and islet autoantibody
positive siblings compared with controls. sL-selectin levels were signific
antly raised in newly diagnosed type I diabetes compared with controls, wit
h intermediate levels in family members, both with and without islet autoan
tibodies, and in long-standing type I diabetes. Levels were also raised in
patients with untreated Graves' disease. Patients with type II diabetes had
sL-selectin levels which did not differ from controls. sL-selectin levels
correlated with the presence of diabetes-associated HLA alleles in both fam
ily members and controls; levels also fell with increasing age in family me
mbers. Multiple regression analysis showed that HLA genotype and age were i
ndependent determinants of sL-selectin levels. sL-selectin levels are raise
d at the time of diagnosis of type I diabetes and Graves' disease and appea
r to be modulated by disease activity, but levels are determined predominan
tly by HLA-associated genetic susceptibility and age. sL-selectin may provi
de a late marker of autoimmune destruction of islets and sequential measure
ment may be useful in monitoring disease activity and the effect of interve
ntions preceding type I diabetes.